Belgian researchers say AI could improve accuracy of diagnosing lung disease

Researchers at the University of Leuven in Belgium said a study they conducted showed artificial intelligence could help interpret, and thereby improve, lung function tests used to diagnose long-term lung disease.

Results of the study were presented Monday at the European Respiratory Society's International Congress.

As part of the study, the researchers used data from 968 people who were undergoing complete lung function testing for the first time.

Event

Join the world's top medtech executives virtually for the leading event in medtech — The Virtual MedTech Conference by AdvaMed

Expect the same high-quality education, world-class speakers and valuable business development in a virtual format. Experience more of the conference with on demand content and partnering, as well as livestreamed sessions.

Using a concept called “machine learning”, they developed an algorithm that takes into account  routine lung function parameters and clinical variables of smoking history, body mass index, and age to make a suggestion for the most likely diagnosis.

"We have demonstrated that artificial intelligence can provide us with a more accurate diagnosis in this new study,” Wim Janssens, senior author of the study, said. “The beauty of our development is that the algorithm can simulate the complex reasoning that a clinician uses to give their diagnosis, but in a more standardized and objective way so it removes any bias. "

Currently, clinicians rely on sifting through results using population-based parameters. By employing AI, the machine can observe a combination of patterns at one time to help produce a more accurate diagnosis.

Last week, Houston Methodist researchers announced they’re using artificial intelligence to quickly and accurately interpret patient charts to help physicians predict breast cancer risk, which they hope reduces unnecessary testing procedures performed as a result of false-positive mammograms.

- check out the release

Related Articles:
Houston Methodist team uses artificial intelligence to predict breast cancer risk 
Artificial intelligence tops Google VC's list of high-potential life sci techs 
EC adds Cellnovo to R&D project to add artificial intelligence in Type 1 diabetes management

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Galecto picked up $64 million to push its lead lung disease treatment toward an approval in Europe and fund midstage studies for its other programs.